临床荟萃

• 论著 • 上一篇    下一篇

二丁酰环磷腺苷钙预防多柔比星化疗后亚急性心脏毒性的临床研究

  

  1. 庆阳市人民医院 中西医结合科,甘肃 庆阳 745000
  • 出版日期:2017-12-05 发布日期:2017-12-14
  • 通讯作者: 通信作者:缪延栋,Email:miaoyandong11@126.com

Clinical study of calcium dibutyryladenosine cyclophosphate in prevention of  subacute cardiotoxicity induced by doxorubicin chemotherapy

  1. Department of Integrated Traditional and Western Medicine, the People’s Hospital
    of Qingyang, Qingyang 745000, China
  • Online:2017-12-05 Published:2017-12-14
  • Contact: Corresponding author: Miao Yandong, Email: miaoyandong11@126.com

摘要: 目的  观察二丁酰环磷腺苷钙预防多柔比星多疗程化疗所致亚急性心脏毒性的疗效。方法  将乳腺癌、非霍奇金淋巴瘤患者47例,随机分为两组,实验组24例,对照组23例,实验组采用化疗联合使用注射用二丁酰环磷腺苷钙;对照组单纯采用含多柔比星的化疗方案.两组患者均按要求完成4周期化疗,观察两组化疗前48小时、2周期化疗后1周、4周期化疗后1周心电图及左心室射血分数(LVEF),N端B型脑钠肽前体(NTproBNP),心肌肌钙蛋白I (cTnI),肌酸激酶同工酶(CKMB)的变化。结果  实验组2周期及4周期化疗后心电图的异常率、LVEF下降百分比、cTnI、NTproBNP和CKMB的水平升高均小于对照组(P<0.05)。结论  注射用二丁酰环磷腺苷钙可以减轻多柔比星多疗程化疗所致的亚急性心脏毒性。

关键词: 乳腺肿瘤, 淋巴瘤, 心脏毒素类, 多柔比星, 二丁酰环磷腺苷钙

Abstract: Objective  To observe the protective effect of calcium dibutyryladenosine cyclophosphate in subacute cardiotoxicity induced by doxorubicin chemotherapy. Methods  Totally 47 cases of breast cancer and lymphoma were randomly divided into control group(n=23)  and treatment group(n=24).  Both groups received the chemotherapy regimens containing doxorubicin and the treatment group had an addition injection of calcium dibutyryladenosine cyclophosphate. Both groups received four complete cycles of chemotherapy. The ECG changes, echocardiography (left ventricular ejection fraction, LVEF), Nterminal probrain natriuretic peptide (NTproBNP), cardiac troponin I (cTnI) and CKMB values in both groups were observed before the chemotherapy and after two and four cycle chemotherapy.Results  Upon comparing the ECG changes, LVEF, cTnI, NTproBNP and CKMB values of both groups before 48 hours of the chemotherapy and after one week of two and four cycle chemotherapy, treatment group had lesser incidence rates in abnormal ECG, decreased LVEF, increased cTnI, NTproBNP and CKMB (P<0.05). Conclusion  Calcium dibutyryladenosine cyclophosphate may reduce the cardiotoxicity induced by doxorubicin chemotherapy.

Key words: breast neoplasms, lymphoma, cardiotoxins, doxorubicin, calcium dibutyryladenosini cyclophosphas